Journal of Urologic Oncology

Renal Cell Carcinoma

A Narrative Review on Systemic Therapy for Renal Cell Carcinoma in the Perioperative Setting: Isamu Tachibana, Qian Qin, Jacob Taylor, Wadih Issa, Jeffrey Cadeddu, Vitaly Margulis, Tian Zhang; Journal of Urologic Oncology. 2024;22(2):100-104. Published online July 31, 2024; DOI: https://doi.org/10.22465/juo.244800500025
Cited By 1; Full text PubReader ePub PDF

Current Update on Prostate Cancer Immunotherapy: Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim; Journal of Urologic Oncology. 2023;21(1):14-22. Published online March 31, 2023; DOI: https://doi.org/10.22465/juo.234600100005; Full text PubReader ePub PDF

2021 Consensus Statements on the Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma From the Korean Renal Cancer Study Group (KRoCS): Chan Ho Lee, Minyong Kang, Cheol Kwak, Sung Han Kim, Jung Kwon Kim, Jae Young Park, Seong Il Seo, Ill Young Seo, Jungyo Suh, Wan Song, Cheryn Song, Hyeong Dong Yuk, Sangchul Lee, Hyung Ho Lee, Jinsoo Chung, Chang Wook Jeong, Jung Ki Jo, Chang Il Choi, Seol Ho Choo, Jun Hyun Han, Eu Chang Hwang, Miso Kim, Chan Kim, Seock Hwan Choi, Sung-Hoo Hong; Korean J Urol Oncol. 2022;20(3):151-162. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.151
Cited By 1; Full text PubReader ePub PDF

Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?: Jae Duck Choi, Jeong Man Cho, Tag Keun Yoo; Korean J Urol Oncol. 2022;20(3):139-150. Published online August 25, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.3.139; Full text PubReader ePub PDF

The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment: Da Som Choi, Su Jeong Kang, In Ho Chang, Young Wook Choi; Korean J Urol Oncol. 2021;19(1):30-39. Published online February 26, 2021; DOI: https://doi.org/10.22465/kjuo.2021.19.1.30; Full text PubReader ePub PDF

Bacillus Calmette-Guérin (BCG)-Cell Wall Skeleton as Immunotherapeutic Option for BCG-Refractory Superficial Bladder Cancer: Young Mi Whang, Da Hyeon Yoon, Gwang Yong Hwang, Young Wook Choi, In Ho Chang; Korean J Urol Oncol. 2019;17(2):88-95. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.88; Full text PubReader ePub PDF

The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers: Gwang Yong Hwang, Se Young Choi, In Ho Chang; Korean J Urol Oncol. 2019;17(2):75-80. Published online August 30, 2019; DOI: https://doi.org/10.22465/kjuo.2019.17.2.75; Full text PubReader ePub PDF

Recombinant Bacille Calmette–Guérin for Immunotherapy in Nonmuscle Invasive Bladder Cancer: Subin Jin, Young Mi Whang, In Ho Chang; Korean J Urol Oncol. 2016;14(3):109-117. Published online December 31, 2016; DOI: https://doi.org/10.22465/kjuo.2016.14.3.109; Full text PubReader ePub PDF

Risk Factors for Metastatic Castrate-Resistant Prostate Cancer: Jae Heon Kim , Won Jae Yang; Korean J Urol Oncol. 2013;11(1):6-10. Published online April 30, 2013; PDF

New Drugs for Castration-resistant Prostate Cancer: Hoon Choi , Jae Young Park , Hong Seok Park; Korean J Urol Oncol. 2012;10(3):124-129. Published online December 30, 2012; PDF

Current Role of Immunotherapy for Advanced Renal Cell Carcinoma in the Era of Targeted Therapy: Hyeong Gon Kim; Korean J Urol Oncol. 2009;7(3):109-112. Published online December 1, 2009; PDF

Update of Intravesical Therapy on Non-Muscle Invasive Bladder Cancer: Hyun Yul Rhew , Taek Sang Kim; Korean J Urol Oncol. 2009;7(1):6-11. Published online April 1, 2009; PDF

5,615	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,064	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,410	The Present and Future of Intravesical Therapy in Bladder Cancer
4,360	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,355	Complex Epidemiology of Prostate Cancer in Asian Countries

Cited By 7	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use

Search